Healios K.K. to Showcase at Chardan's 9th Annual Conference on Genetic Medicines
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 20 2025
0mins
Source: Globenewswire
Healios Presentation Announcement: Richard Kincaid, CFO of Healios K.K., will present at the Chardan 9th Annual Genetic Medicines Conference on October 21, 2025, at 2:00 PM ET, with a live and archived webcast available on Chardan’s website.
About Healios: Healios K.K. is a leading Japanese biotechnology company focused on regenerative medicine using stem cells, developing therapies like MultiStem® for various diseases and HLCN061 for solid tumors, with ongoing clinical trials and innovative manufacturing processes.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
